RETINITIS PIGMENTOSA (RP)
Clinical trials for RETINITIS PIGMENTOSA (RP) explained in plain language.
Never miss a new study
Get alerted when new RETINITIS PIGMENTOSA (RP) trials appear
Sign up with your email to follow new studies for RETINITIS PIGMENTOSA (RP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye injection aims to slow blindness in rare genetic disease
Disease control OngoingThis study tests an experimental drug called ultevursen for people with retinitis pigmentosa caused by a specific gene mutation (USH2A). The drug is injected into the eye and may help slow vision loss. The trial involves 81 participants, some of whom will receive a sham (fake) in…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could a blood extract save sight? early trial tests PRP for rare eye diseases
Disease control OngoingThis pilot study tests whether injections of platelet-rich plasma (PRP) made from a patient's own blood can help preserve vision in people with retinitis pigmentosa or a related condition called EMAP. Thirty participants receive three injections over four months, and researchers …
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase: PHASE1, PHASE2 • Sponsor: Rubens Camargo Siqueira • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can an arthritis drug save sight? small trial tests adalimumab for rare eye diseases
Disease control OngoingThis pilot study tests whether adalimumab, an anti-inflammatory drug, can help preserve vision in people with retinitis pigmentosa or a related condition called EMAP. Thirty participants will receive three injections into the eye over four months. The main goal is to see if the t…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase: PHASE1, PHASE2 • Sponsor: Centro de Pesquisa Rubens Siqueira • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC